Posted on December 2, 2008 in delirium news by Valerie PageComments Off

The proposal for a UK multicentre double blinded RCT haloperidol vs. placebo in ventilated patients is being presented at this years ICS State of the Art meeting. This study will answer that million dollar question – does treating critically ill patients with haloperidol actually improve outcomes i.e. death, cognitive function? If you want to know the answer come along to the Balmoral Suite on the Monday December 15th 14.00 and vote for UK-MIND as proposed by Valerie Page and Wes Ely.